Indian Paclitaxel Exporters: Complete Supplier Ranking with Market Share — 959 Manufacturers (2026) — TransData Nexus

Q: Who is the largest paclitaxel buyer importing from India?

FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) is the largest paclitaxel importer from India with a 20.6% market share and import value of $17.2M.

Q: How many paclitaxel buyers import from India?

There are 959 active paclitaxel buyers importing from India, with a combined import market of $83.1M across 4,928 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top paclitaxel buyers from India?

The top 5 paclitaxel buyers — FRESENIUS KABI DEUTSCHLAND GMBH, OOO"JODAS EXPOIM", APOTEX CORP, J. KNIPPER & COMPANY, OOOJODAS EXPOIM — together control 30.9% of total paclitaxel import value from India.

Suresh Sormare

Paclitaxel

India Pharmaceutical Trade Intelligence

$83.1M319 Suppliers142 CountriesHS 30049044

ExportsIndia → GERMANY20.6%India → UNITED STATES13.1%

ImportsSOUTH KOREA → India$1.6B UNITED STATES → India$2.3M

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Market Analysis: Top Importing Countries & Their Importers

1Germany

Germany emerges as the first largest importing country, achieving a total trade value of $17.2M through 513 shipments. This represents a market share of 20.6% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Germany has a diverse importer base, with their top importers including:

• FRESENIUS KABI DEUTSCHLAND GMBH - $17.2M (100.0% of country's total business)

Key Insight: Germany demonstrates strong market positioning with an average shipment value of $33.4K, indicating premium pricing strategy compared to the market average of $16.9K.

Germany is a key market for Paclitaxel imports, representing 20.6% of total trade value.

Primary Market

Secondary Market

2United States

United States emerges as the second largest importing country, achieving a total trade value of $10.9M through 96 shipments. This represents a market share of 13.1% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Paclitaxel buyer market intelligence

1Buyer Segment Analysis

The importers of Paclitaxel from India can be categorized into several key segments:

1. Pharmaceutical Distributors: Entities like FRESENIUS KABI DEUTSCHLAND GMBH (Germany) and APOTEX CORP (Canada) fall into this category. These distributors procure large quantities of Paclitaxel to supply hospitals, clinics, and pharmacies within their respective regions. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure a steady supply chain.

2. Contract Manufacturers: Companies such as OOO "JODAS EXPOIM" (Russia) and ACCORD FARMACUTICA LTDA. (Brazil) are contract manufacturers that import Paclitaxel as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and client demands, often involving substantial volumes to meet manufacturing needs.

3. Hospital and Healthcare Providers: Organizations like J. KNIPPER & COMPANY and AMERICAN HEALTH PACKAGING (both from the United States) represent hospital groups and healthcare providers. They import Paclitaxel to administer directly to patients within their facilities. Their purchasing behavior typically involves regular, smaller shipments to maintain adequate inventory levels for patient treatment.

4. Re-exporters: Some entities may act as intermediaries, importing Paclitaxel from India and then exporting it to other countries. This segment's buying behavior is influenced by global market demands and regulatory considerations, often involving variable order sizes and frequencies.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

Country-Specific Import Regulations

TransData Nexus Paclitaxel buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Paclitaxel from India, the import regulations are as follows:

1. Germany:

Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

Import Registration Process: Importers must obtain a marketing authorization from BfArM, which involves submitting a comprehensive dossier including quality, safety, and efficacy data.

Estimated Timeline for Registration: Approximately 7 to 12 months, depending on the completeness of the application and any additional information requests.

Import Tariff/Duty for HS 30049044: Pharmaceutical products under this HS code are generally exempt from import duties within the European Union.

2. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Demand Drivers & Market Opportunity

TransData Nexus Paclitaxel buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Paclitaxel in importing countries is driven by several key factors:

1. Rising Cancer Incidence: The global increase in cancer cases, particularly breast, ovarian, and lung cancers, has led to a heightened need for effective chemotherapy agents like Paclitaxel. For instance, the World Health Organization estimated a significant rise in new cancer cases annually, underscoring the growing demand for such treatments.

2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs and striving for universal health coverage, which includes access to essential medicines. This expansion facilitates greater access to cancer treatments, thereby boosting the demand for Paclitaxel.

3. WHO Essential Medicines List Procurement: Paclitaxel's inclusion in the World Health Organization's Essential Medicines List highlights its critical role in cancer treatment, prompting governments and healthcare organizations to prioritize its procurement.

4. Tender-Based Purchasing: Many healthcare systems utilize tender-based purchasing for pharmaceuticals, which can lead to bulk procurement of Paclitaxel, ensuring a steady supply and potentially reducing costs.

With 959 buyers across 142 countries, the global reach and consistent demand for Paclitaxel underscore its importance in oncology treatment and present significant market opportunities for suppliers.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Paclitaxel Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest paclitaxel buyer importing from India?

Based on import volume and value, FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) leads with $17.2M in imports and a 20.6% market share — the highest of any single paclitaxel importer. OOO"JODAS EXPOIM" (RUSSIA) and APOTEX CORP (CANADA) are the next largest buyers.

QHow many companies buy paclitaxel from India?

There are 959 active paclitaxel buyers importing from India, with a combined market of $83.1M across 4,928 shipments to 142 countries. The top 5 buyers hold 30.9% of total import value, while the remaining 954 buyers handle the other 69.1%.

QWhich countries import the most paclitaxel from India?

The top importing countries for paclitaxel from India are Germany (20.6%), United States (13.1%), Russia (7.0%), Canada (7.0%), Thailand (5.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of paclitaxel, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for paclitaxel from India?

The average import transaction value for paclitaxel from India is $16.9K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Paclitaxel buyer market intelligence

1Buyer Segment Analysis

The importers of Paclitaxel from India can be categorized into several key segments:

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

Country-Specific Import Regulations

TransData Nexus Paclitaxel buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Paclitaxel from India, the import regulations are as follows:

1. Germany:

Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

Import Registration Process: Importers must obtain a marketing authorization from BfArM, which involves submitting a comprehensive dossier including quality, safety, and efficacy data.

Estimated Timeline for Registration: Approximately 7 to 12 months, depending on the completeness of the application and any additional information requests.

Import Tariff/Duty for HS 30049044: Pharmaceutical products under this HS code are generally exempt from import duties within the European Union.

2. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Demand Drivers & Market Opportunity

TransData Nexus Paclitaxel buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Paclitaxel in importing countries is driven by several key factors:

With 959 buyers across 142 countries, the global reach and consistent demand for Paclitaxel underscore its importance in oncology treatment and present significant market opportunities for suppliers.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Paclitaxel

Paclitaxel

Who Buys Paclitaxel from India — 959 Importers Behind a $83.1M Market

Top Paclitaxel Importers — Ranked by Import Value

Top Paclitaxel Buyers & Importers

Related Analysis

Need Details?

Paclitaxel — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Paclitaxel — and from which countries?

Paclitaxel — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Germany

2United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Paclitaxel Buyers & Importers

QWho is the largest paclitaxel buyer importing from India?

QHow many companies buy paclitaxel from India?

QWhich countries import the most paclitaxel from India?

QWhat is the average import order value for paclitaxel from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Russia

4Canada

5Thailand

Analysis Methodology